Company intelligence / Profile preview

Bellberry

Adelaide, South Australia, Australiabellberry.com.au ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Bellberry provides independent, high-quality scientific and ethical review of human research projects in Australia. It reviews approximately 40% of Clinical Trial Notification trials in the country, with a strong focus on early-phase studies including First in Human and Phase 1 trials. The company also supports animal ethics through a pilot AEC program focused on pharmacology and toxicology studies involving rodents.

Industry: Contract Research Organization

Partnerships

CT:Iq consortium with ACTA, NHMRC Clinical Trials Centre, The George Institute—focused on improving clinical trial quality and impact in Australia

Beyond the preview

Go deeper on Bellberry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bellberry.

Explore the full profile